Publicacions en què col·labora amb Noemí Fabelo Pulido (17)

2024

  1. Evidence for alterations in lipid profiles and biophysical properties of lipid rafts from spinal cord in sporadic amyotrophic lateral sclerosis

    Journal of Molecular Medicine, Vol. 102, Núm. 3, pp. 391-402

2018

  1. “Lipid raft aging” in the human frontal cortex during nonpathological aging: gender influences and potential implications in Alzheimer's disease

    Neurobiology of Aging, Vol. 67, pp. 42-52

2017

  1. Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases

    Neurobiology of Aging, Vol. 49, pp. 52-59

2016

  1. Lipid raft alterations in aged-associated neuropathologies

    Current Alzheimer Research, Vol. 13, Núm. 9, pp. 973-984

2015

  1. Docosahexaenoic (DHA) modulates phospholipid-hydroperoxide glutathione peroxidase (Gpx4) gene expression to ensure self-protection from oxidative damage in hippocampal cells

    Frontiers in Physiology, Vol. 6, Núm. JUL

  2. Hippocampal lipid homeostasis in APP/PS1 mice is modulated by a complex interplay between dietary DHA and estrogens: Relevance for Alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 49, Núm. 2, pp. 459-481

2014

  1. Addition of docosahexaenoic acid, but not arachidonic acid, activates glutathione and thioredoxin antioxidant systems in murine hippocampal HT22 cells: Potential implications in neuroprotection

    Journal of Neurochemistry, Vol. 131, Núm. 4, pp. 470-483

  2. Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions

    Neurobiology of Aging, Vol. 35, Núm. 8, pp. 1801-1812

  3. Biophysical alterations in lipid rafts from human cerebral cortex associate with increased BACE1/AβPP interaction in early stages of Alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 43, Núm. 4, pp. 1185-1198

2013

  1. Lipid raft disarrangement as a result of neuropathological progresses: A novel strategy for early diagnosis?

    Neuroscience, Vol. 245, pp. 26-39

  2. Oestrogens as modulators of neuronal signalosomes and brain lipid homeostasis related to protection against neurodegeneration

    Journal of Neuroendocrinology, Vol. 25, Núm. 11, pp. 1104-1115

2012

  1. Effects of Oestradiol on Brain Lipid Class and Fatty Acid Composition: Comparison Between Pregnant and Ovariectomised Oestradiol-Treated Rats

    Journal of Neuroendocrinology, Vol. 24, Núm. 2, pp. 292-309

  2. Evidence for premature lipid raft aging in APP/PS1 double-transgenic mice, a model of familial Alzheimer disease

    Journal of Neuropathology and Experimental Neurology, Vol. 71, Núm. 10, pp. 868-881

  3. Genotype-induced changes in biophysical properties of frontal cortex lipid raft from APP/PS1 transgenic mice

    Frontiers in Physiology, Vol. 3 NOV

2011

  1. Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease.

    Molecular medicine (Cambridge, Mass.), Vol. 17, Núm. 9-10, pp. 1107-1118

2010

  1. Lipid alterations in lipid rafts from Alzheimer's disease human brain cortex

    Journal of Alzheimer's Disease, Vol. 19, Núm. 2, pp. 489-502

2006

  1. Selective polyunsaturated fatty acids enrichment in phospholipids from neuronal-derived cell lines

    Journal of Neuroscience Methods, Vol. 153, Núm. 2, pp. 230-238